Russell Investments Group
CLB icon

Russell Investments Group’s Core Laboratories CLB Stock Holding History

Russell Investments Group’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.25M Buy
193,517
+45,180
+30% +$645K ﹤0.01% 2024
2026
Q1 		$2.49M Sell
148,337
-7,159
-5% -$128K ﹤0.01% 1752
2025
Q4 		$2.49M Sell
155,496
-89,952
-37% -$1.34M ﹤0.01% 1750
2025
Q3 		$3.03M Buy
245,448
+48,456
+25% +$568K ﹤0.01% 1623
2025
Q2 		$2.27M Buy
196,992
+44,949
+30% +$533K ﹤0.01% 1666
2025
Q1 		$2.28M Sell
152,043
-60,780
-29% -$1.02M ﹤0.01% 1618
2024
Q4 		$3.68M Buy
212,823
+45,739
+27% +$883K 0.01% 1321
2024
Q3 		$3.1M Sell
167,084
-58,499
-26% -$1.17M ﹤0.01% 1455
2024
Q2 		$4.58M Buy
225,583
+157,252
+230% +$2.78M 0.01% 1193
2024
Q1 		$1.17M Sell
68,331
-43,959
-39% -$691K ﹤0.01% 1915
2023
Q4 		$1.98M Buy
112,290
+36,560
+48% +$737K ﹤0.01% 1620
2023
Q3 		$1.82M Buy
75,730
+74,976
+9,944% +$1.84M ﹤0.01% 1603
2023
Q2 		$17.5K Hold
754
– – ﹤0.01% 2862
2023
Q1 		$16.6K Buy
+754
New +$17.6K ﹤0.01% 2836
2022
Q2 		– Sell
-38,472
Closed -$1.22M – 2895
2022
Q1 		$1.22M Buy
+38,472
New +$1.08M ﹤0.01% 1864
2020
Q1 		– Sell
-5,941
Closed -$229K – 3042
2019
Q4 		$229K Buy
5,941
+216
+4% +$9.71K ﹤0.01% 2660
2019
Q3 		$267K Sell
5,725
-71,755
-93% -$3.34M ﹤0.01% 2504
2019
Q2 		$4.05M Sell
77,480
-80,964
-51% -$4.75M 0.01% 1341
2019
Q1 		$10.9M Sell
158,444
-13,755
-8% -$922K 0.02% 852
2018
Q4 		$10.3M Sell
172,199
-136,319
-44% -$11.8M 0.02% 792
2018
Q3 		$35.7M Sell
308,518
-66,650
-18% -$7.52M 0.07% 327
2018
Q2 		$47.3M Sell
375,168
-157,389
-30% -$19.2M 0.1% 212
2018
Q1 		$57.5M Sell
532,557
-273,707
-34% -$30.3M 0.1% 247
2017
Q4 		$87.5M Sell
806,264
-89,141
-10% -$8.9M 0.15% 154
2017
Q3 		$88.4M Buy
895,405
+86,407
+11% +$8.38M 0.15% 153
2017
Q2 		$81.9M Buy
808,998
+41,026
+5% +$4.42M 0.15% 153
2017
Q1 		$88.7M Sell
767,972
-56,050
-7% -$6.51M 0.16% 134
2016
Q4 		$98.2M Buy
+824,022
New +$91.2M 0.19% 118

Other funds holding CLB

AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DGI
Disciplined Growth Investors Minneapolis, Minnesota $5.91B AUM 53.97% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CAMG
CWA Asset Management Group Naples, Florida $3.28B AUM 34.07% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Russell Investments Group's CLB Position: Q2 2026 in Review

Russell Investments Group increased its Core Laboratories (CLB) stake by 30% in Q2 2026, buying an estimated $645K and bringing the position to 193,517 shares worth $2.25M. The position accounts for ﹤0.01% of the portfolio, ranked #2024.

Russell Investments Group first reported a position in CLB in Q4 2016 and has held it in 28 quarters since. The position peaked at $98.2M in Q4 2016. 186 funds tracked by Wall St. Rank hold CLB as of Q2 2026.

  • Russell Investments Group held 193,517 shares of Core Laboratories worth $2.25M as of Q2 2026.
  • Russell Investments Group bought 45,180 Core Laboratories shares in Q2 2026, an estimated $645K.
  • Core Laboratories made up ﹤0.01% of Russell Investments Group's portfolio in Q2 2026, its #2024 holding.
  • Russell Investments Group first reported a position in Core Laboratories in Q4 2016 and has held it in 28 quarters since.
  • Russell Investments Group's Core Laboratories position peaked at $98.2M in Q4 2016.
  • 186 funds tracked by Wall St. Rank held Core Laboratories as of Q2 2026.

Based on Russell Investments Group's 13F filing for Q2 2026, filed 6 Aug 2026.